Cargando…

Immunohistochemical Analysis of CD99 and PAX8 in a Series of 15 Molecularly Confirmed Cases of Ewing Sarcoma

Ewing sarcomas are an uncommon group of malignant neoplasms. A multidisciplinary approach is highly recommended to reach a correct diagnosis, considering the clinical, radiological, and histopathological aspects. Since in up to 90% of cases, the translocation t (11; 22) (q24; q12) occurs resulting i...

Descripción completa

Detalles Bibliográficos
Autores principales: Chinchilla-Tábora, LM., Ortiz Rodríguez-Parets, J., González Morais, I., Sayagués, J. M., Ludeña de la Cruz, M. D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341420/
https://www.ncbi.nlm.nih.gov/pubmed/32675940
http://dx.doi.org/10.1155/2020/3180798
_version_ 1783555235793338368
author Chinchilla-Tábora, LM.
Ortiz Rodríguez-Parets, J.
González Morais, I.
Sayagués, J. M.
Ludeña de la Cruz, M. D.
author_facet Chinchilla-Tábora, LM.
Ortiz Rodríguez-Parets, J.
González Morais, I.
Sayagués, J. M.
Ludeña de la Cruz, M. D.
author_sort Chinchilla-Tábora, LM.
collection PubMed
description Ewing sarcomas are an uncommon group of malignant neoplasms. A multidisciplinary approach is highly recommended to reach a correct diagnosis, considering the clinical, radiological, and histopathological aspects. Since in up to 90% of cases, the translocation t (11; 22) (q24; q12) occurs resulting in a chimeric fusion transcript EWSR1-FLI-1. The pathologist has several tools in addition to conventional techniques (hematoxylin and eosin), such as immunohistochemistry, which plays a very important role in the differential diagnosis. We present a series of 15 cases of molecularly confirmed ES, in which we found a sensitivity of 100% for CD99 and 80% for PAX8 by immunohistochemistry. This indicates a high sensitivity; however, it is known that both CD99 and PAX8 are also expressed in other tumours. Therefore, molecular confirmation should be performed in all cases.
format Online
Article
Text
id pubmed-7341420
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-73414202020-07-15 Immunohistochemical Analysis of CD99 and PAX8 in a Series of 15 Molecularly Confirmed Cases of Ewing Sarcoma Chinchilla-Tábora, LM. Ortiz Rodríguez-Parets, J. González Morais, I. Sayagués, J. M. Ludeña de la Cruz, M. D. Sarcoma Research Article Ewing sarcomas are an uncommon group of malignant neoplasms. A multidisciplinary approach is highly recommended to reach a correct diagnosis, considering the clinical, radiological, and histopathological aspects. Since in up to 90% of cases, the translocation t (11; 22) (q24; q12) occurs resulting in a chimeric fusion transcript EWSR1-FLI-1. The pathologist has several tools in addition to conventional techniques (hematoxylin and eosin), such as immunohistochemistry, which plays a very important role in the differential diagnosis. We present a series of 15 cases of molecularly confirmed ES, in which we found a sensitivity of 100% for CD99 and 80% for PAX8 by immunohistochemistry. This indicates a high sensitivity; however, it is known that both CD99 and PAX8 are also expressed in other tumours. Therefore, molecular confirmation should be performed in all cases. Hindawi 2020-06-17 /pmc/articles/PMC7341420/ /pubmed/32675940 http://dx.doi.org/10.1155/2020/3180798 Text en Copyright © 2020 LM. Chinchilla-Tábora et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Chinchilla-Tábora, LM.
Ortiz Rodríguez-Parets, J.
González Morais, I.
Sayagués, J. M.
Ludeña de la Cruz, M. D.
Immunohistochemical Analysis of CD99 and PAX8 in a Series of 15 Molecularly Confirmed Cases of Ewing Sarcoma
title Immunohistochemical Analysis of CD99 and PAX8 in a Series of 15 Molecularly Confirmed Cases of Ewing Sarcoma
title_full Immunohistochemical Analysis of CD99 and PAX8 in a Series of 15 Molecularly Confirmed Cases of Ewing Sarcoma
title_fullStr Immunohistochemical Analysis of CD99 and PAX8 in a Series of 15 Molecularly Confirmed Cases of Ewing Sarcoma
title_full_unstemmed Immunohistochemical Analysis of CD99 and PAX8 in a Series of 15 Molecularly Confirmed Cases of Ewing Sarcoma
title_short Immunohistochemical Analysis of CD99 and PAX8 in a Series of 15 Molecularly Confirmed Cases of Ewing Sarcoma
title_sort immunohistochemical analysis of cd99 and pax8 in a series of 15 molecularly confirmed cases of ewing sarcoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341420/
https://www.ncbi.nlm.nih.gov/pubmed/32675940
http://dx.doi.org/10.1155/2020/3180798
work_keys_str_mv AT chinchillataboralm immunohistochemicalanalysisofcd99andpax8inaseriesof15molecularlyconfirmedcasesofewingsarcoma
AT ortizrodriguezparetsj immunohistochemicalanalysisofcd99andpax8inaseriesof15molecularlyconfirmedcasesofewingsarcoma
AT gonzalezmoraisi immunohistochemicalanalysisofcd99andpax8inaseriesof15molecularlyconfirmedcasesofewingsarcoma
AT sayaguesjm immunohistochemicalanalysisofcd99andpax8inaseriesof15molecularlyconfirmedcasesofewingsarcoma
AT ludenadelacruzmd immunohistochemicalanalysisofcd99andpax8inaseriesof15molecularlyconfirmedcasesofewingsarcoma